These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20331473)

  • 21. Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain.
    Kumar M; O'Connell M; Namekar M; Nerurkar VR
    Viruses; 2014 Jun; 6(6):2328-39. PubMed ID: 24915459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
    Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
    Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
    Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.
    Capone G; Lucchese G; Calabrò M; Kanduc D
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):64-70. PubMed ID: 23116371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.
    Pinto AK; Richner JM; Poore EA; Patil PP; Amanna IJ; Slifka MK; Diamond MS
    J Virol; 2013 Feb; 87(4):1926-36. PubMed ID: 23221549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.
    Schepp-Berglind J; Luo M; Wang D; Wicker JA; Raja NU; Hoel BD; Holman DH; Barrett AD; Dong JY
    Clin Vaccine Immunol; 2007 Sep; 14(9):1117-26. PubMed ID: 17634508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
    Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
    Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
    Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
    J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
    Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
    Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.
    Hobson-Peters J; Toye P; Sánchez MD; Bossart KN; Wang LF; Clark DC; Cheah WY; Hall RA
    J Gen Virol; 2008 Dec; 89(Pt 12):3063-3072. PubMed ID: 19008394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baboon model for West Nile virus infection and vaccine evaluation.
    Wolf RF; Papin JF; Hines-Boykin R; Chavez-Suarez M; White GL; Sakalian M; Dittmer DP
    Virology; 2006 Nov; 355(1):44-51. PubMed ID: 16904151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
    Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.
    Hofmeister Y; Planitzer CB; Farcet MR; Teschner W; Butterweck HA; Weber A; Holzer GW; Kreil TR
    J Virol; 2011 Feb; 85(4):1896-9. PubMed ID: 21123389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV.
    Patel S; Sinigaglia A; Barzon L; Fassan M; Sparber F; LeibundGut-Landmann S; Ackermann M
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31277274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine.
    Karkashan A
    Front Immunol; 2024; 15():1395870. PubMed ID: 38799422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular basis of antibody protection against West Nile virus.
    Mehlhop E; Diamond MS
    Curr Top Microbiol Immunol; 2008; 317():125-53. PubMed ID: 17990792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of Tissue-Specific CD8
    Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.